Fabio Blandini
Fabio Blandini
C. Mondino National Neurological Institute
Dirección de correo verificada de mondino.it - Página principal
Título
Citado por
Citado por
Año
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini, G Nappi, C Tassorelli, E Martignoni
Progress in neurobiology 62 (1), 63-88, 2000
6502000
Glutamate and Parkinson’s disease
F Blandini, RHP Porter, JT Greenamyre
Molecular neurobiology 12 (1), 73-94, 1996
3531996
Animal models of Parkinson’s disease
F Blandini, MT Armentero
The FEBS journal 279 (7), 1156-1166, 2012
3412012
The 6-hydroxydopamine model: news from the past
F Blandini, MT Armentero, E Martignoni
Parkinsonism & related disorders 14, S124-S129, 2008
2992008
Plasma Homocysteine and l-DOPA Metabolism in Patients with Parkinson Disease
F Blandini, R Fancellu, E Martignoni, A Mangiagalli, C Pacchetti, ...
Clinical Chemistry 47 (6), 1102-1104, 2001
1642001
Naproxen sodium in menstrual migraine prophylaxis: A double‐blind placebo controlled study
G Sances, E Martignoni, L Fioroni, F Blandini, F Facchinetti, G Nappi
Headache: The Journal of Head and Face Pain 30 (11), 705-709, 1990
1641990
Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues …
F Blandini, G Levandis, E Bazzini, G Nappi, MT Armentero
European Journal of Neuroscience 25 (2), 397-405, 2007
1612007
Cognitive and affective status in mild hypothyroidism and interactions with l‐thyroxine treatment
G Bono, R Fancellu, F Blandini, G Santoro, M Mauri
Acta Neurologica Scandinavica 110 (1), 59-66, 2004
1542004
Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat
F Blandini, L Cova, MT Armentero, E Zennaro, G Levandis, P Bossolasco, ...
Cell transplantation 19 (2), 203-218, 2010
1472010
Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease
F Blandini, MT Armentero, R Fancellu, E Blaugrund, G Nappi
Experimental neurology 187 (2), 455-459, 2004
1402004
Multiple neurogenic and neurorescue effects of human mesenchymal stem cell after transplantation in an experimental model of Parkinson's disease
L Cova, MT Armentero, E Zennaro, C Calzarossa, P Bossolasco, G Busca, ...
Brain research 1311, 12-27, 2010
1292010
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
G Ambrosi, S Cerri, F Blandini
Journal of neural transmission 121 (8), 849-859, 2014
1272014
Neural and immune mechanisms in the pathogenesis of Parkinson’s disease
F Blandini
Journal of Neuroimmune Pharmacology 8 (1), 189-201, 2013
1202013
Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
G Levandis, E Bazzini, MT Armentero, G Nappi, F Blandini
Neurobiology of disease 29 (1), 161-168, 2008
1092008
Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease
F Blandini, E Sinforiani, C Pacchetti, A Samuele, E Bazzini, R Zangaglia, ...
Neurology 66 (4), 529-534, 2006
1022006
Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a …
MT Armentero, R Fancellu, G Nappi, P Bramanti, F Blandini
Neurobiology of disease 22 (1), 1-9, 2006
962006
A new 5‐HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double‐blind study vs amitriptyline
G Nappi, G Sandrini, F Granella, L Ruiz, G Cerutti, F Facchinetti, ...
Headache: The Journal of Head and Face Pain 30 (7), 439-444, 1990
93*1990
SOD1 and DJ-1 converge at Nrf2 pathway: a clue for antioxidant therapeutic potential in neurodegeneration
P Milani, G Ambrosi, O Gammoh, F Blandini, C Cereda
Oxidative medicine and cellular longevity 2013, 2013
902013
An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease
F Blandini
Functional neurology 25 (2), 65, 2010
772010
Subthalamic infusion of an NMDA antagonist prevents basal ganglia metabolic changes and nigral degeneration in a rodent model of Parkinson's disease
F Blandini, G Nappi, JT Greenamyre
Annals of neurology 49 (4), 525-529, 2001
772001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20